AI assistant
Sending…
Zymeworks Inc. — Director's Dealing 2024
Dec 12, 2024
32180_dirs_2024-12-12_53560804-0728-4ca4-ae7e-1423b6e9f6ab.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Zymeworks Inc. (ZYME)
CIK: 0001937653
Period of Report: 2024-12-10
Reporting Person: Davidson Nancy (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-12-10 | Stock Option (Right to Buy) | $13.06 | A | 31000 | Acquired | 2034-12-09 | Common Stock (31000) | Direct |
Footnotes
F1: Stock options vest on date of next annual general meeting following grant date of December 10, 2024.